MizMaa Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
NOVOSnovoslabs.comin𝕏Apr 2022 · $6M
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms.
BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness
Chris Mirabile(Founder & CEO)in
Co-investorsCornucopian Capital ManagementFab Co-Creation Studio VenturesResolute VenturesKaedan CapitalRemagine VenturesUNCOMMON DENOMINATOR
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.